Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-05T15:02:45.022Z Has data issue: false hasContentIssue false

39 - Fibrocystic Liver Disease

from SECTION V - OTHER CONDITIONS AND ISSUES IN PEDIATRIC HEPATOLOGY

Published online by Cambridge University Press:  18 December 2009

Maureen M. Jonas M.D.
Affiliation:
Associate Professor, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; Associate in Gastroenterology, Department of Medicine, Division of Gastroenterology, Children's Hospital Boston, Boston, Massachusetts
Antonio R. Perez-Atayde M.D.
Affiliation:
Associate Professor of Pathology, Department of Pathology, Children's Hospital Boston, Boston, Massachusetts
Frederick J. Suchy
Affiliation:
Mount Sinai School of Medicine, New York
Ronald J. Sokol
Affiliation:
University of Colorado, Denver
William F. Balistreri
Affiliation:
University of Cincinnati
Get access

Summary

Fibrocystic liver disease refers to a heterogeneous group of disorders that share some pathophysiologic and clinical features but have important differences. Cystic dilatation of intrahepatic bile duct structures and variable degrees of portal fibrosis are the hallmarks of fibrocystic liver disease. In most instances, there are morphologic abnormalities in the kidneys and pancreas that parallel those of the liver. For this reason, and to appreciate more thoroughly the shared pathogenesis and implications for organogenesis, fibrocystic liver disease and corresponding renal counterparts are discussed together.

It has been recognized for centuries that hepatic and renal cysts are seen in the same individuals [1], although it has not always been accepted that they are manifestations of the same diseases [2]. The older literature contains confusing descriptive classifications of fibrocystic diseases, with imprecise and overlapping definitions. Even now, attempts at describing clinical and radiographic features, prognosis, natural history, and treatment are somewhat hampered by reliance on these descriptive reports. However, much of the molecular basis for these disorders has been elucidated, and clinical diagnoses are being modified using more exact genetic criteria. The current consensus is that genetic determinants of differentiation and development of renal tubules and biliary structures result in a broad spectrum of congenital abnormalities grouped under the heading of fibrocystic liver and kidney disease [3].

Embryologic development of the liver has been discussed elsewhere (see Chapter 1) and will not be fully reviewed here.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bristowe, C. Cystic disease of the liver associated with a similar disease of the kidneys. Trans Pathol Soc Lond 1856;7:229–34.Google Scholar
Karhunen, P J, Tenhu, M. Adult polycystic liver and kidney diseases are separate entities. Clin Genet 1986;30:29–37.CrossRefGoogle ScholarPubMed
D'Agata, I D A, Jonas, M M, Perez-Atayde, A R, Guay-Woodford, L M. Combined cystic disease of the liver and kidney. Semin Liv Dis 1994;14:215–28.CrossRefGoogle ScholarPubMed
Jorgensen, M J. The ductal plate malformation. Acta Pathol Microbiol Immunol Scand Suppl A 1977;257:1–88.Google Scholar
Desmet, V J. Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation.”Hepatology 1992;16:1069–83.CrossRefGoogle ScholarPubMed
Eycken, P, Sciot, R, Callea, F. The development of the intrahepatic bile duct in man: a keratin-immunohistochemical study. Hepatology 1988;8:1586–95.CrossRefGoogle Scholar
Stosiek, P, Kasper, M, Marsten, V. Expression of cytokeratin 19 during human liver organogenesis. Liver 1990;10:59–63.CrossRefGoogle ScholarPubMed
Desmet, V J, Eycken, P, Scito, R. Cytokeratins for probing cell lineage relation in developing liver. Hepatology 1990;12:1249–51.CrossRefGoogle Scholar
Desmet, V J. Embryology of the liver and intrahepatic biliary tract, and an overview of malformations of the bile duct. In: McIntyre, N, Benhamou, J-P, Bircher, J, Rizzetto, M, Rodes, J. The Oxford textbook of clinical hepatology. Oxford, England: Oxford University Press; 1991:497–519.Google Scholar
Ruebner, B H, Blankenberg, T A, Burrows, D A. Development and transformation of the ductal plate in the developing human liver. Pediatr Pathol 1990;10:55–68.CrossRefGoogle ScholarPubMed
Shah, K D, Gerber, M A. Development of intrahepatic bile ducts in humans. Arch Path Lab Med 1990;114:597–600.Google ScholarPubMed
Osathanondh, V, Potter, E L. Development of the human kidney as shown by microdissection. Arch Pathol 1963;76:277–302.Google ScholarPubMed
Saxen, L. Organogenesis of the kidney. Cambridge, England: Cambridge University Press; 1987.CrossRefGoogle ScholarPubMed
Black, D D, Suttle, E A, Whitington, G L. The effect of short term TPN in hepatic function in the human neonate: a prospective randomized study demonstrating alteration of hepatic canalicular function. J Pediatr 1981;99:445–9.CrossRefGoogle ScholarPubMed
Lieberman, E, Salinas-Madrigal, L, Gwinn, J L. Infantile polycystic kidney disease of the kidney and liver: clinical, pathologic and radiologic correlations and comparison with congenital hepatic fibrosis. Medicine (Baltimore) 1971;50:277–318.CrossRefGoogle Scholar
Zerres, K, Volpel, M-C, Weiss, H. Cystic kidneys: genetics, pathologic anatomy, clinical picture and prenatal diagnosis. Hum Genet 1984;68:104–35.CrossRefGoogle ScholarPubMed
Gabow, P A. Autosomal dominant polycystic kidney disease. N Engl J Med 1993;329:332–42.CrossRefGoogle ScholarPubMed
Pretorius, D H, Lee, M E, Manco-Johnson, M L. Diagnosis of autosomal dominant polycystic kidney disease in utero and the young infant. J Ultrasound Med 1987;6:249–55.CrossRefGoogle ScholarPubMed
Donovan, M J, Kozakewich, H, Perez-Atayde, A. Solitary nonparasitic cysts of the liver. Pediatr Pathol Lab Med 1995;15:419–28.CrossRefGoogle ScholarPubMed
Pul, N, Pul, M. Congenital solitary nonparasitic cyst of the liver in infancy and childhood. J Pediatr Gastroenterol Nutr 1995;21:461–2.CrossRefGoogle ScholarPubMed
Kerr, D N S, Harrison, C V, Sherlock, S. Congenital hepatic fibrosis. Q J Med 1961;30:91–117.Google ScholarPubMed
Gang, D, Herrin, J T. Infantile polycystic disease of the liver and kidneys. Clin Nephrol 1986;25:28–36.Google ScholarPubMed
Kaplan, B S, Fay, J, Shah, V. Autosomal recessive polycystic kidney disease. Pediatr Nephrol 1989;3:43–9.CrossRefGoogle ScholarPubMed
Blythe, H, Ockenden, B G. Polycystic disease of the kidneys and liver presenting in childhood. J Med Genet 1971;8:257–84.CrossRefGoogle Scholar
Onuchic, L F, Furu, L, Nagasaka, Y. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunogloulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet 2002;70:1305–17.CrossRefGoogle ScholarPubMed
Ward, C J, Hogan, M C, Rossetti, S. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 2002;30:259–69.CrossRefGoogle ScholarPubMed
Rossetti, S, Torra, R, Coto, E. A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney Int 2003;64:391–403.CrossRefGoogle ScholarPubMed
Averback, P. Congenital hepatic fibrosis: asymptomatic adults without renal anomaly. Arch Path Lab Med 1977;101:260–1.Google ScholarPubMed
Tazelaar, H D, Payne, J A, Patel, S. Congenital hepatic fibrosis and asymptomatic familiary adult type polycystic disease in a 19 year old woman. Gastroenterology 1984;86:757–60.Google Scholar
Witzleben, C L, Sharp, A. Nephronophthisis-congenital hepatic fibrosis: an additional hepatorenal disorder. Hum Pathol 1982;13:728–33.CrossRefGoogle ScholarPubMed
Harris, H W, Carpenter, T O, Stanley, P. Progressive tubulointerstitial renal disease in infancy with associated hepatic abnormalities. Am J Med 1986;81:169–76.CrossRefGoogle ScholarPubMed
Lewis, S M, Roberts, E A, Marcon, M A. Joubert syndrome with congenital hepatic fibrosis: an entity in the spectrum of oculo-encephalo-hepato-renal disorders. Am J Med Genet 1994;52:419–26.CrossRefGoogle ScholarPubMed
Blankenberg, T A, Ruebner, B H, Ellis, W G. Pathology of renal and hepatic anomalies in Meckel syndrome. Am J Med Genet 1987;Suppl 3:395–410.CrossRefGoogle Scholar
Cideciyan, D, Rodriguez, M M, Haun, R L. New findings in short rib syndrome. Am J Med Genet 1993;46:255–9.CrossRefGoogle ScholarPubMed
Ivemark, B I, Oldfelt, V, Zetterstrom, R. Familial dysplasia of kidneys, liver and pancreas: a probably genetically determined syndrome. Acta Paediatr 1959;48:1–11.Google ScholarPubMed
Torra, R, Alos, L, Ramos, J, Estivill, X. Renal–hepatic–pancreatic dysplasia: an autosomal recessive malformation. J Med Genet 1996;33:409–12.CrossRefGoogle Scholar
Verloes, A, Lambotte, C. Further delineation of a syndrome of cerebellar vermis hypo/aplasia, oligophrenia, congenital ataxia, coloboma, and hepatic fibrosis. Am J Med Genet 1989;32:227–32.CrossRefGoogle ScholarPubMed
Alvarez, F, Bernard, O, Brunelle, F. Congenital hepatic fibrosis in children. J Pediatr 1981;99:370–5.CrossRefGoogle ScholarPubMed
Summerfeld, J A, Nagafuchi, Y, Sherlock, S. Hepatobiliary fibropolycystic diseases. A clinical and histologic review of 51 patients. J Hepatol 1986;2:141–56.CrossRefGoogle Scholar
Desmet, V J. What is congenital hepatic fibrosis?Histopathology 1992;20:465–77.CrossRefGoogle ScholarPubMed
Blankenberg, T A, Lund, J K, Reubner, B H. Normal and abnormal development of human intrahepatic bile ducts: an immunohistochemical perspective. In: Abramowsky, C R, Bernstein, J, Rosenberg, H S. Perspectives in pediatric pathology: Transplantation pathology – hepatic morphogenesis. Basel, Switzerland: Karger; 1991:143–67.Google Scholar
Kerr, D N S, Okonkwo, S, Choa, R G. Congenital hepatic fibrosis: the long term prognosis. Gut 1978;19:514–20.CrossRefGoogle ScholarPubMed
Guay-Woodford, L M, Bryda, E C, Christine, B. Evidence that two phenotypically distinct mouse PKD mutations, bpk and jcpk, are allelic. Kidney Int 1996;50:1158–65.CrossRefGoogle ScholarPubMed
Fiorillo, R A, Migliorati, R, Vajro, P, Caldore, M. Congenital hepatic fibrosis with GI bleeding in early infancy. Clin Pediatr 1982;21:183–5.CrossRefGoogle ScholarPubMed
Bernstein, J, Slovis, T L. Polycystic diseases of the kidney. In: Edelmann, C M. Pediatric jidney disease. Boston: Little, Brown; 1992:1139–53.Google ScholarPubMed
Caroli, J, Couinaud, C, Soupault, R. Une affection nouvelle, sans doute congénitale, des voies biliaires: la dilatation cystique unilobaire des canaux hépatiques. Sem Hop Paris 1958;34:136–42.Google Scholar
Kocoshis, S A, Riely, C A, Burrell, M, Gryboski, J. Cholangitis in a child due to biliary tract anomalies. Dig Dis Sci 1980;25:59–65.CrossRefGoogle Scholar
Jordan, D, Harpaz, N, Thung, S N. Caroli's disease and adult polycystic kidney disease: a rarely recognized association. Liver 1989;9:30–5.CrossRefGoogle Scholar
Todani, T, Watanabe, Y, Narusue, M. Congenital bile duct cysts: classification, operative procedures and review of thirty seven cases including cancer arising from choledochal cyst. Am J Surg 1977;134:263–9.CrossRefGoogle ScholarPubMed
Lowenfels, A. Does bile promote extracolonic cancer?Lancet 1978;2:239–41.CrossRefGoogle Scholar
Raymond, M-J, Huguet, C, Danan, G. Partial hepatectomy in the treatment of Caroli's disease. Dig Dis Sci 1984;29:367–70.CrossRefGoogle Scholar
Welling, L W, Grantham, J J. Cystic and developmental diseases of the kidney. In: Brenner, B M, Rector, F C. The kidney. Philadelphia: WB Saunders, 1991:33–6.Google Scholar
Grunfeld, J P, Albouze, G, Junger, P. Liver changes and complications in adult polycystic kidney disease. Adv Nephrol 1985;14:1–20.Google ScholarPubMed
Lipschitz, B, Berdon, W E, Defelice, A R, Levy, J. Association of congenital hepatic fibrosis with autosomal dominant polycystic kidney disease. Pediatr Radiol 1993;23:131–3.CrossRefGoogle ScholarPubMed
Reeders, S T, Breuning, M H, Davies, K E. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 1985;317:542–4.CrossRefGoogle ScholarPubMed
Kimberling, W J, Kumar, S, Gabow, P A. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics 1993;18:467–72.CrossRefGoogle ScholarPubMed
Peters, D J M, Spruit, L, Sarris, J J. Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat Genet 1993;5:359–62.CrossRefGoogle ScholarPubMed
Ariza, M, Alvarez, V, Marin, R. A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes. J Med Genet 1997;34:587–9.CrossRefGoogle ScholarPubMed
Desmet, V J. Ludwig symposium on biliary disorders – part I. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 1998;73:80–9.CrossRefGoogle ScholarPubMed
Otha, W, Ushio, H. Histological reconstruction of von Meyenberg's complex on the liver surface. Endoscopy 1984;16:71–4.Google Scholar
Homer, L W, White, H J, Read, R C. Neoplastic transformation of von Meyenburg complexes of the liver. J Pathol Bacteriol 1968;96:499–502.CrossRefGoogle Scholar
Honda, N, Cobb, C, Lechago, J. Bile duct carcinoma associated with multiple von Meyenburg complexes in the liver. Hum Pathol 1986;17:1287–90.CrossRefGoogle Scholar
Burns, C D, Kuhns, J G, Wieman, T J. Cholangiocarcinoma in association with multiple biliary microhamartomas. Arch Path Lab Med 1990;114:1287–9.Google ScholarPubMed
Everson, G T. Hepatic cysts in autosomal dominant polycystic kidney disease (editorial). Mayo Clin Proc 1990;65:1020–5.CrossRefGoogle Scholar
Gabow, P A, Johnson, A M, Kaehny, W D. Risk factors for the development of hepatic cysts in autosomal dominant polycystic disease. Hepatology 1990;11:1033–7.CrossRefGoogle Scholar
Ramos, A, Torres, V E, Holley, K E. The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch Path Lab Med 1990;114:180–4.Google ScholarPubMed
Pirson, Y, Lannoy, N, Peters, D. Isolated polycystic liver disease as a distinct genetic disease, unlinked to polycystic kidney disease 1 and polycystic kidney disease 2. Hepatology 1996;23:249–52.CrossRefGoogle ScholarPubMed
Iglesias, D M, Palmitano, J A, Arrizurieta, E. Isolated polycystic liver disease not linked to polycystic kidney disease 1 and 2. Dig Dis Sci 1999;44:385–8.CrossRefGoogle Scholar
Qian, Q, Li, A, King, B F. Clinical profile of autosomal dominant polycystic liver disease. Hepatology 2003;37:164–71.CrossRefGoogle ScholarPubMed
Drenth, J P, Tahvanainen, E, te Morsche, R H. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease. Hepatology: Official journal of the American Association for the Study of Liver Diseases 2004;39:924–31.CrossRefGoogle ScholarPubMed
Jaeken, J, Matthijs, G, Saudubray, J-M. Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic–intestinal presentation. Am J Hum Genet 1998;62:1535–9.CrossRefGoogle ScholarPubMed
Telenti, A, Torres, V E, Gross, J B. Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc 1990;65:933–42.CrossRefGoogle ScholarPubMed
Newman, K D, Torres, V E, Rakela, J, Nagorney, D N. Treatment of highly symptomatic polycystic liver disease. Ann Surg 1990;212:30–7.CrossRefGoogle ScholarPubMed
Kabbej, M, Sauvanet, A, Chauveau, D. Laparoscopic fenestration in polycystic liver disease. Brit J Surg 1996;83:1697–701.CrossRefGoogle ScholarPubMed
Gigot, J F, Jadoul, P, Que, F. Adult polycystic liver disease: is fenestration the most adequate operation for long-term management?Ann Surg 1997;225:286–94.CrossRefGoogle ScholarPubMed
Martin, I J, McKinley, A J, Currie, E J. Tailoring the management of nonparasitic liver cysts. Ann Surg 1998;228:167–72.CrossRefGoogle ScholarPubMed
Washburn, W K, Johnson, L B, Lewis, W D, Jenkins, R L. Liver transplantation for adult polycystic liver disease. Liv Transplant Surg 1996;2:17–22.CrossRefGoogle ScholarPubMed
Swenson, K, Seu, P, Kinkhabwala, M. Liver transplantation for adult polycystic liver disease. Hepatology 1998;28:412–15.CrossRefGoogle ScholarPubMed
Taub, M, Laurie, G W, Martin, G R. Altered basement membrane protein biosynthesis by primary cultures of cpk/cpk mouse kidney. Kidney Int 1990;37:1090–7.CrossRefGoogle ScholarPubMed
Calvet, J P. Polycystic kidney disease: primary extracellular matrix abnormality or defective cellular differentiation?Kidney Int 1993;43:101–8.CrossRefGoogle ScholarPubMed
Avner, E D, Studnicki, F E, Young, M C. Congenital murine polycystic disease. Pediatr Nephrol 1987;1:587–96.CrossRefGoogle Scholar
Wilson, P D, Sherwood, A C. Tubulocystic epithelium. Kidney Int 1991;39:450–63.CrossRefGoogle ScholarPubMed
Hjelle, J T, Waterds, D C, Golinska, B T. Autosomal recessive polycystic kidney disease: characterization of human peritoneal and cystic kidney cells in vitro. Am J Kidney Dis 1990;15:123–36.CrossRefGoogle ScholarPubMed
Wilson, P D, Du, J, Norman, J T. Autocrine, endocrine, and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease. Eur J Cell Biol 1993;61:131–8.Google ScholarPubMed
Du, J, Wilson, P D. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am J Physiol 1995;269:C487–95.CrossRefGoogle ScholarPubMed
Avner, E D, Sweeney, W E. Polypeptide growth factors in metanephric growth and segmental nephron differentiation. Pediatr Nephrol 1990;4:372–7.CrossRefGoogle ScholarPubMed
Lowden, Da, Lindemann, gw, Merlino, G. Renal cysts in transgenic mice expressing transforming growth factor-alpha. J Lab Clin Med 1994;124:386–94.Google ScholarPubMed
Richards, W G, Sweeney, W E, Yoder, B K. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J Clin Invest 1998;101:935–9.CrossRefGoogle ScholarPubMed
Wilson, P D, Sherwood, A C, Palla, K. Reversed polarity of Na+K+-ATPase: mislocation to apical plasma membranes in human polycystic kidney disease epithelia. Am J Physiol 1992;260:F1–11.Google Scholar
Avner, E D, Sweeney, W E, Nelson, W J. Abnormal sodium pump distribution during renal tubulogenesis in congenital murine polycystic kidney disease. Proc Natl Acad Sci U S A 1992;89:7447–51.CrossRefGoogle ScholarPubMed
Gattone, V H, Calvet, J P, Cowley, B D. Autosomal recessive polycystic kidney disease in a murine model: a gross and microscopic description. Lab Invest 1988;59:231–8.Google Scholar
Crocker, J F A, Blecher, S R, Givner, M L. Polycystic kidney and liver disease and corticosterone changes in the CPK mouse. Kid Internat 1987;31:1088–91.CrossRefGoogle ScholarPubMed
Cowley, B D, Chadwick, L J, Grantham, J J. Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse. J Am Soc Nephrol 1991;1:1048–53.Google ScholarPubMed
Carone, F A, Nakanura, S, Schumacher, B S. Cyst-derived cells do not exhibit accelerated growth or features of transformed cells in vitro. Kidney Int 1989;35:1351–7.CrossRefGoogle ScholarPubMed
Nauta, J, Ozawa, Y, Sweeney, W E. Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease. Pediatr Nephrol 1993;7:163–72.CrossRefGoogle Scholar
Nauta, J, Sweeney, W E, Rutledge, J C. Biliary epithelial cells from mice with congenital polycystic kidney disease are hyperresponsive to epidermal growth factor. Pediatr Res 1995;37:755–63.CrossRefGoogle ScholarPubMed
Onuchic, L F, Schrick, J J, Ma, J. Sequence analysis of the human hTg737gene and its polymorphic sites in patients with autosomal recessive polycystic kidney disease. Mamm Genome 1995;5:805–8.CrossRefGoogle Scholar
Yoder, B K, Wilkinson, J E, Avner, E D. The Tg737 protein interacts with polycystin and proteins controlling epithelial polarity, EGFR stability and cellular differentiation. J Am Soc Nephrol 1997;8:386A.Google Scholar
Yoder, M K, Richard, W G, Sommardahl, C. Functional correction of renal defects in a mouse model for ARPKD through expression of the cloned wild-type Tg737 cDNA. Kidney Int 1996;50:1240–8.CrossRefGoogle Scholar
Yoder, B K, Richards, W G, Sommerdahl, C. Differential rescue of the renal and hepatic disease in an autosomal recessive polycystic kidney disease mouse mutant. A new model to study the liver lesion. Am J Pathol 1997;150:2231–41.Google Scholar
Tian, Y W, Smith, P G, Yeoh, G C. The oval-shaped cell as a candidate for a liver stem cell in embryonic, neonatal and precancerous liver: identification based on morphology and immunohistochemical staining for albumin and pyruvate kinase isoenzyme expression. Histochem Cell Biol 1997;107:243–50.CrossRefGoogle ScholarPubMed
Isfort, R J, Cody, D B, Doersen, C J. The tetratricopeptide repeat containing Tg737 gene is a liver neoplasia tumor suppressor gene. Oncogene 1997;15:1797–803.CrossRefGoogle ScholarPubMed
Al-Bhalal, L, Akhtar, M. Molecular basis of autosomal dominant polycystic kidney disease. Adv Anat Pathol 2005;12:126–33.CrossRefGoogle ScholarPubMed
Lu, W, Peissel, B, Babakhanlou, H. Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation. Nat Genet 1997;17:179–81.CrossRefGoogle Scholar
Lu, W, Fan, X, Basora, N. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes [letter]. Nat Genet 1999;21:160–1.CrossRefGoogle Scholar
The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995;81:289–98.CrossRef
Qian, F, Germino, F J, Cai, Y. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet 1997;16:179–83.CrossRefGoogle ScholarPubMed
Geng, L, Segal, Y, Peissel, B. Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 1996;98:2674–82.CrossRefGoogle ScholarPubMed
Qian, F, Watnick, T J, Onuchic, L F, Germino, G G. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996;87:979–87.CrossRefGoogle ScholarPubMed
Mochizuki, T, Wu, G, Hayashi, T. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996;272:1339–42.CrossRefGoogle ScholarPubMed
Nauli, S M, Alenghat, F J, Luo, Y. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 2003;33:129–37.CrossRefGoogle ScholarPubMed
Pazour, G J, Dickert, B L, Vucica, Y. ChlamydomonasIFT88 and its mouse homologue, polycystic kidney disease gene Tg737, are required for assembly of cilia and flagella. J Cell Biol 2000;151:709–18.CrossRefGoogle ScholarPubMed
Bergmann, C, Senderek, J, KÃ1/4pper, F. PKHD1 mutations in autosomal recessive polycystic kidney disease ([ARPKD)]. Hum Mutat 2004;23:453–63.CrossRefGoogle Scholar
Zhang, M-Z, Mai, W, Li, C. PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. Proc Natl Acad Sci U S A 2004;101:2311–16.CrossRefGoogle ScholarPubMed
Wang, S, Luo, Y, Wilson, P D, Witman, G B, Zhou, J. The autosomal recessive polycystic kidney disease protein is localized to primary cilia, with concentration in the basal body area. J Am Soc Nephrol 2004;15:592–602.CrossRefGoogle ScholarPubMed
Masyuk, T V, Huang, B Q, Masyuk, A I. Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease. Am J Pathol 2004;165:1719–30.CrossRefGoogle ScholarPubMed
Hepinstall, R H. Pathology of the kidney. 4th ed. Boston: Little, Brown, 1992.Google Scholar
El-Youssef, M, Mu, Y, Huang, L, Stellmach, V, Crawford, S E. Increased expression of transforming growth factor-β1 and thrombospondin-1 in congenital hepatic fibrosis: possible role of the hepatic stellate cell. J Pediatr Gastroenterol Nutr 1999;28:386–92.CrossRefGoogle ScholarPubMed
Whitley, C B, Schwarzenberg, S J, Burke, B A. Direct hyperbilirubinemia and hepatic fibrosis: a new presentation of Jeune syndrome (asphyxiating thoracic dystrophy). Am J Med Genet 1987;Suppl 3:211–20.CrossRefGoogle Scholar
Pelletier, V A, Galéano, N, Brochu, P. Secretory diarrhea with protein-losing enteropathy, enterocolitis cystica superficialis, intestinal lymphangiectasia, and congenital hepatic fibrosis: a new syndrome. J Pediatr 1985;107:61–5.Google Scholar
Nishimura, G, Nakayama, M, Fuke, Y, Suehara, N. A lethal osteo-chondrodysplasia with mesomelic brachymelia, round pelvis, and congenital hepatic fibrosis. Pediatr Radiol 1998;28:43–7.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Fibrocystic Liver Disease
    • By Maureen M. Jonas, M.D., Associate Professor, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; Associate in Gastroenterology, Department of Medicine, Division of Gastroenterology, Children's Hospital Boston, Boston, Massachusetts, Antonio R. Perez-Atayde, M.D., Associate Professor of Pathology, Department of Pathology, Children's Hospital Boston, Boston, Massachusetts
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.041
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Fibrocystic Liver Disease
    • By Maureen M. Jonas, M.D., Associate Professor, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; Associate in Gastroenterology, Department of Medicine, Division of Gastroenterology, Children's Hospital Boston, Boston, Massachusetts, Antonio R. Perez-Atayde, M.D., Associate Professor of Pathology, Department of Pathology, Children's Hospital Boston, Boston, Massachusetts
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.041
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Fibrocystic Liver Disease
    • By Maureen M. Jonas, M.D., Associate Professor, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; Associate in Gastroenterology, Department of Medicine, Division of Gastroenterology, Children's Hospital Boston, Boston, Massachusetts, Antonio R. Perez-Atayde, M.D., Associate Professor of Pathology, Department of Pathology, Children's Hospital Boston, Boston, Massachusetts
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.041
Available formats
×